Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.

MD·NYSE

$21.84

+1.0%
HealthcareMedical - Care Facilities

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

At a Glance

Live Snapshot
Market Cap$1.79B
EPS1.9400
P/E Ratio11.26
Earnings Date08/04/2026

md

Cash at End of Period

Last Annual Value

375.24M

3-Year CAGR

237%

5-Year CAGR

-20%

10-Year CAGR

22%

Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. Competitors Analysis of Cash at End of Period

MD · NYSE
CompanyCash at End of Period
CAGR 3Y
CAGR 5Y
CAGR 10Y
375.24M
72.4%-0.6%21.0% 
112.19M
-3.8%-1.3%13.5%
248.64M
46.7%10.9%N/A
709.60M
17.5%-0.2%22.6%
434.05M
13.8%13.2%N/A
26.52M
-31.9%-18.6%-12.3%
574.00M
-6.1%-4.9%N/A
193.26M
63.8%44.7%N/A
133.24M
10.0%-0.1%8.9%
81.62M
8.0%-13.5%26.1%
65.62M
343.5%34.3%N/A
Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. Fair Value Envelope

MD · NYSE

Our analysis suggests that MD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $21.84, this represents a potential HIDDEN relative to our calculated worth for Pediatrix Medical Group, Inc..

Intrinsic Value
Current Price: $21.84